183 related articles for article (PubMed ID: 12145174)
1. Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study.
Lindi VI; Uusitupa MI; Lindström J; Louheranta A; Eriksson JG; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Laakso M; Tuomilehto J;
Diabetes; 2002 Aug; 51(8):2581-6. PubMed ID: 12145174
[TBL] [Abstract][Full Text] [Related]
2. Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects.
Niskanen L; Lindi V; Erkkilä A; Sivenius K; Luoma J; Ylä-Herttuala S; Laakso M; Uusitupa MI
Metabolism; 2003 Feb; 52(2):213-7. PubMed ID: 12601635
[TBL] [Abstract][Full Text] [Related]
3. The Pro12Ala polymorphism of the PPAR gamma 2 gene regulates weight from birth to adulthood.
Pihlajamäki J; Vanhala M; Vanhala P; Laakso M
Obes Res; 2004 Feb; 12(2):187-90. PubMed ID: 14981210
[TBL] [Abstract][Full Text] [Related]
4. [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].
Fu M; Chen H; Li X; Li J; Wu B; Cheng L; Cai M; Fu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):234-8. PubMed ID: 12048686
[TBL] [Abstract][Full Text] [Related]
5. Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians.
Ek J; Andersen G; Urhammer SA; Hansen L; Carstensen B; Borch-Johnsen K; Drivsholm T; Berglund L; Hansen T; Lithell H; Pedersen O
Diabetologia; 2001 Sep; 44(9):1170-6. PubMed ID: 11596673
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study.
Herrmann SM; Ringel J; Wang JG; Staessen JA; Brand E;
Diabetes; 2002 Aug; 51(8):2653-7. PubMed ID: 12145184
[TBL] [Abstract][Full Text] [Related]
7. Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial.
Andrulionytè L; Zacharova J; Chiasson JL; Laakso M;
Diabetologia; 2004 Dec; 47(12):2176-84. PubMed ID: 15592662
[TBL] [Abstract][Full Text] [Related]
8. The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on insulin sensitivity and insulin metabolism interact with size at birth.
Eriksson JG; Lindi V; Uusitupa M; Forsén TJ; Laakso M; Osmond C; Barker DJ
Diabetes; 2002 Jul; 51(7):2321-4. PubMed ID: 12086968
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
Andrulionyte L; Peltola P; Chiasson JL; Laakso M;
Diabetes; 2006 Jul; 55(7):2148-52. PubMed ID: 16804087
[TBL] [Abstract][Full Text] [Related]
10. Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects.
Oh EY; Min KM; Chung JH; Min YK; Lee MS; Kim KW; Lee MK
J Clin Endocrinol Metab; 2000 May; 85(5):1801-4. PubMed ID: 10843155
[TBL] [Abstract][Full Text] [Related]
11. Effect of the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue of massively obese subjects.
Kolehmainen M; Uusitupa MI; Alhava E; Laakso M; Vidal H
J Clin Endocrinol Metab; 2003 Apr; 88(4):1717-22. PubMed ID: 12679463
[TBL] [Abstract][Full Text] [Related]
12. The peroxisome proliferator-activated receptor-gamma2 gene polymorphism (Pro12Ala) beneficially influences insulin resistance and its tracking from childhood to adulthood: the Bogalusa Heart Study.
Li S; Chen W; Srinivasan SR; Boerwinkle E; Berenson GS;
Diabetes; 2003 May; 52(5):1265-9. PubMed ID: 12716762
[TBL] [Abstract][Full Text] [Related]
13. Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight.
Doney A; Fischer B; Frew D; Cumming A; Flavell DM; World M; Montgomery HE; Boyle D; Morris A; Palmer CN
BMC Genet; 2002 Nov; 3():21. PubMed ID: 12429071
[TBL] [Abstract][Full Text] [Related]
14. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes.
Hara K; Okada T; Tobe K; Yasuda K; Mori Y; Kadowaki H; Hagura R; Akanuma Y; Kimura S; Ito C; Kadowaki T
Biochem Biophys Res Commun; 2000 Apr; 271(1):212-6. PubMed ID: 10777704
[TBL] [Abstract][Full Text] [Related]
15. Impact of Prol2Ala variant in the peroxisome proliferator-activated receptor (PPAR) gamma2 on obesity and insulin resistance in Japanese Type 2 diabetic and healthy subjects.
Kawasaki I; Tahara H; Emoto M; Shoji T; Shioji A; Okuno Y; Inaba M; Nishizawa Y
Osaka City Med J; 2002 Jun; 48(1):23-8. PubMed ID: 12375694
[TBL] [Abstract][Full Text] [Related]
16. Common polymorphisms in the genes regulating the early insulin signalling pathway: effects on weight change and the conversion from impaired glucose tolerance to Type 2 diabetes. The Finnish Diabetes Prevention Study.
Laukkanen O; Pihlajamäki J; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
Diabetologia; 2004 May; 47(5):871-7. PubMed ID: 15127203
[TBL] [Abstract][Full Text] [Related]
17. Association of the Leu72Met polymorphism of the ghrelin gene with the risk of Type 2 diabetes in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study.
Mager U; Lindi V; Lindström J; Eriksson JG; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Laakso M; Pulkkinen L; Uusitupa M;
Diabet Med; 2006 Jun; 23(6):685-9. PubMed ID: 16759313
[TBL] [Abstract][Full Text] [Related]
18. Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus.
Tavares V; Hirata RD; Rodrigues AC; Monte O; Salles JE; Scalissi N; Speranza AC; Hirata MH
Diabetes Obes Metab; 2005 Sep; 7(5):605-11. PubMed ID: 16050954
[TBL] [Abstract][Full Text] [Related]
19. The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences.
Douglas JA; Erdos MR; Watanabe RM; Braun A; Johnston CL; Oeth P; Mohlke KL; Valle TT; Ehnholm C; Buchanan TA; Bergman RN; Collins FS; Boehnke M; Tuomilehto J
Diabetes; 2001 Apr; 50(4):886-90. PubMed ID: 11289057
[TBL] [Abstract][Full Text] [Related]
20. Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study.
Kao WH; Coresh J; Shuldiner AR; Boerwinkle E; Bray MS; Brancati FL;
Diabetes; 2003 Jun; 52(6):1568-72. PubMed ID: 12765972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
